Diversity-oriented synthesis of glycomimetics

被引:0
作者
Michael Meanwell
Gaelen Fehr
Weiwu Ren
Bharanishashank Adluri
Victoria Rose
Johannes Lehmann
Steven M. Silverman
Rozhin Rowshanpour
Christopher Adamson
Milan Bergeron-Brlek
Hayden Foy
Venugopal Rao Challa
Louis-Charles Campeau
Travis Dudding
Robert Britton
机构
[1] Simon Fraser University,Department of Chemistry
[2] Merck & Co.,Department of Process Research and Development
[3] Inc,Department of Chemistry
[4] Brock University,undefined
来源
Communications Chemistry | / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Glycomimetics are structural mimics of naturally occurring carbohydrates and represent important therapeutic leads in several disease treatments. However, the structural and stereochemical complexity inherent to glycomimetics often challenges medicinal chemistry efforts and is incompatible with diversity-oriented synthesis approaches. Here, we describe a one-pot proline-catalyzed aldehyde α-functionalization/aldol reaction that produces an array of stereochemically well-defined glycomimetic building blocks containing fluoro, chloro, bromo, trifluoromethylthio and azodicarboxylate functional groups. Using density functional theory calculations, we demonstrate both steric and electrostatic interactions play key diastereodiscriminating roles in the dynamic kinetic resolution. The utility of this simple process for generating large and diverse libraries of glycomimetics is demonstrated in the rapid production of iminosugars, nucleoside analogues, carbasugars and carbohydrates from common intermediates.
引用
收藏
相关论文
共 136 条
[1]  
Overend WG(1973)Detection of carbohydrate structures on isolated subcellular organelles of rat liver by heterophile agglutinins Nature 242 71-71
[2]  
Ernst B(2009)From carbohydrate leads to glycomimetic drugs Nat. Rev. Drug Discov. 8 661-677
[3]  
Magnani JL(2015)Carbohydrate drugs: current status and development prospect Drug Discov. Ther. 9 79-87
[4]  
Zhang Y(2009)Glycomimetic drugs-a new source of therapeutic opportunities Discov. Med. 8 247-252
[5]  
Wang F(2020)Design and synthesis of glycomimetics: recent advances Med. Res. Rev. 40 495-531
[6]  
Magnani JL(2007)Synthesis and conformational and biological aspects of carbasugars Chem. Rev. 107 1919-2036
[7]  
Ernst B(2018)Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design J. Med. Chem. 61 5822-5880
[8]  
Tamburrini A(2000)Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor Curr. Med. Chem. 7 663-672
[9]  
Colombo C(2000)Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus Drugs 59 521-549
[10]  
Bernardi A(2000)Target-oriented and diversity-oriented organic synthesis in drug discovery Science 287 1964-58